{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T02:52:18Z","timestamp":1781751138136,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"capital insititute of pediatrics foundation for youths","award":["QN-2024-24"],"award-info":[{"award-number":["QN-2024-24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Temple syndrome (TS14) is a rare imprinting disorder caused by dysregulation of imprinted genes in the 14q32 region. Although several cohorts have been reported, pediatric data from China are still lacking. This study aimed to characterize the clinical features in Chinese children with TS14 and evaluate their response to recombinant human growth hormone (rhGH), including outcomes associated with initiating treatment before two years of age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicenter retrospective review was conducted involving seven children diagnosed with TS14 across six pediatric centers in China. Clinical characteristics, growth parameters, genetic testing, and treatment outcomes were extracted from medical records. Molecular diagnosis was established by methylation-specific assays, with additional molecular-genetic testing performed as indicated. Changes in height standard deviation score (SDS) were analyzed descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven patients (1 male, 6 females) were included, with a median age at diagnosis of 2.0 (IQR: 0.67\u20137.33) years. Maternal UPD(14) was confirmed in one case and strongly suspected in three cases, whereas in the remaining three cases the underlying mechanism could not be determined. Most patients were small for gestational age (71.4%) and all exhibited growth retardation, delayed language development, dysmorphic features, with feeding difficulties (85.7%), and hypotonia (71.4%). All three older children subsequently developed central precocious puberty. Six patients who were initiated on rhGH therapy before puberty (median age at initiation, 2.42 years), achieved a mean height SDS increase of 1.19 after one year. Among the three patients treated before age two, the mean height SDS gain was 1.15, with caregiver-reported improvements in motor and language development, and no adverse events reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This inaugural TS14 cohort from China shows clinical features largely consistent with those reported in international cohorts, with a high frequency of precocious puberty among older patients. rhGH therapy yielded substantial short-term gains in height, and initiation of treatment before age two was accompanied by caregiver-reported developmental improvements, although standardized developmental assessments were not available. Early genetic diagnosis and timely intervention are essential, while long-term outcomes require further study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-06898-0","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:14:27Z","timestamp":1776932067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth hormone therapy in children with temple syndrome: the first retrospective study in China"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"6898_CR1","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1080\/15592294.2018.1514233","volume":"13","author":"J Beygo","year":"2018","unstructured":"Beygo J, Mertel C, Kaya S, et al. The origin of imprinting defects in Temple syndrome and comparison with other imprinting disorders. Epigenetics. 2018;13:822\u20138. https:\/\/doi.org\/10.1080\/15592294.2018.1514233.","journal-title":"Epigenetics"},{"key":"6898_CR2","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1093\/hmg\/ddaa133","volume":"29","author":"R Prasasya","year":"2020","unstructured":"Prasasya R, Grotheer KV, Siracusa LD, Bartolomei MS. Temple syndrome and Kagami-Ogata syndrome: clinical presentations, genotypes, models and mechanisms. Hum Mol Genet. 2020;29:R107\u201316. https:\/\/doi.org\/10.1093\/hmg\/ddaa133.","journal-title":"Hum Mol Genet"},{"key":"6898_CR3","doi-asserted-by":"publisher","first-page":"e3041","DOI":"10.1210\/clinem\/dgae883","volume":"110","author":"T Ogawa","year":"2025","unstructured":"Ogawa T, Narusawa H, Nagasaki K, et al. Temple syndrome: comprehensive clinical study in genetically confirmed 60 japanese patients. J Clin Endocrinol Metabolism. 2025;110:e3041\u201351. https:\/\/doi.org\/10.1210\/clinem\/dgae883.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"6898_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/jmedgenet-2014-102396","volume":"51","author":"Y Ioannides","year":"2014","unstructured":"Ioannides Y, Lokulo-Sodipe K, Mackay DJ, Davies JH, Temple IK. Temple syndrome: improving the recognition of an underdiagnosed chromosome 14 imprinting disorder: an analysis of 51 published cases. J Med Genet. 2014;51:495\u2013501. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102396.","journal-title":"J Med Genet"},{"key":"6898_CR5","doi-asserted-by":"publisher","first-page":"dgaa461","DOI":"10.1210\/clinem\/dgaa461","volume":"105","author":"L Montenegro","year":"2020","unstructured":"Montenegro L, Labarta JI, Piovesan M, et al. Novel genetic and biochemical findings of DLK1 in children with central precocious puberty: a Brazilian-Spanish study. J Clin Endocrinol Metabolism. 2020;105:dgaa461. https:\/\/doi.org\/10.1210\/clinem\/dgaa461.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"6898_CR6","doi-asserted-by":"publisher","first-page":"dev185918","DOI":"10.1242\/dev.185918","volume":"147","author":"M Kitazawa","year":"2020","unstructured":"Kitazawa M, Hayashi S, Imamura M, et al. Deficiency and overexpression of Rtl1 in the mouse cause distinct muscle abnormalities related to temple and Kagami-Ogata syndromes. Development. 2020;147:dev185918. https:\/\/doi.org\/10.1242\/dev.185918.","journal-title":"Development"},{"key":"6898_CR7","doi-asserted-by":"publisher","unstructured":"Juriaans AF, Kerkhof GF, Mahabier EF et al. Temple syndrome: clinical findings, body composition and cognition in 15 patients. J Clin Med. 2022;11:6289. https:\/\/doi.org\/10.3390\/jcm11216289. Published 2022 Oct 25.","DOI":"10.3390\/jcm11216289"},{"key":"6898_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/cge.13244","volume":"93","author":"G Gillessen-Kaesbach","year":"2018","unstructured":"Gillessen-Kaesbach G, Albrecht B, Eggermann T, et al. Molecular and clinical studies in 8 patients with Temple syndrome. Clin Genet. 2018;93:1179\u201388. https:\/\/doi.org\/10.1111\/cge.13244.","journal-title":"Clin Genet"},{"key":"6898_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000496700","volume":"90","author":"DS Brightman","year":"2018","unstructured":"Brightman DS, Lokulo-Sodipe O, Searle BA, et al. Growth hormone improves short-term growth in patients with temple syndrome. Hormone Res Paediatrics. 2018;90:407\u201313. https:\/\/doi.org\/10.1159\/000496700.","journal-title":"Hormone Res Paediatrics"},{"key":"6898_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1159\/000530420","volume":"96","author":"AF Juriaans","year":"2023","unstructured":"Juriaans AF, Trueba-Timmermans DJ, Kerkhof GF, et al. The effects of 5 years of growth hormone treatment on growth and body composition in patients with temple syndrome. Hormone Res Paediatrics. 2023;96:483\u201394. https:\/\/doi.org\/10.1159\/000530420.","journal-title":"Hormone Res Paediatrics"},{"key":"6898_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4274\/jcrpe.galenos.2022.2022-9-19","volume":"16","author":"N Yordanova","year":"2024","unstructured":"Yordanova N, Iotova V, Mackay DJG, Temple IK, Stoyanova S, Hachmeriyan M. Long-term follow-up of a late diagnosed patient with temple syndrome. J Clin Res Pediatr Endocrinol. 2024;16:475\u201380. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2022.2022-9-19.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"01","key":"6898_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3760\/cma.j.cn112140-20220802-00693","volume":"61","author":"Chinese Society of Pediatric Endocrinology and Inherited Metabolic Diseases, Chinese Medical Association","year":"2023","unstructured":"Chinese Society of Pediatric Endocrinology and Inherited Metabolic Diseases, Chinese Medical Association. Editorial Board of Chinese Journal of Pediatrics. Expert consensus on the diagnosis and treatment of central precocious puberty (2022). Chin J Pediatr. 2023;61(01):16\u201322. https:\/\/doi.org\/10.3760\/cma.j.cn112140-20220802-00693.","journal-title":"Chin J Pediatr"},{"issue":"07","key":"6898_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3760\/cma.j.issn.0578-1310.2009.07.003","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji C, Zong X, et al. Standardized growth charts for height and weight of Chinese children and adolescents aged 0\u201318 years. Chin J Pediatr. 2009;47(07):487\u201392. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2009.07.003.","journal-title":"Chin J Pediatr"},{"key":"6898_CR14","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/gim.2017.53","volume":"19","author":"M Kagami","year":"2017","unstructured":"Kagami M, Nagasaki K, Kosaki R, et al. Temple syndrome: Comprehensive molecular and clinical findings in 32 Japanese patients. Genet Sci. 2017;19:1356\u201366. https:\/\/doi.org\/10.1038\/gim.2017.53.","journal-title":"Genet Sci"},{"key":"6898_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13148-024-01652-8","volume":"16","author":"N Baena","year":"2024","unstructured":"Baena N, Monk D, Aguilera C, et al. Novel 14q32.2 paternal deletion encompassing the whole DLK1 gene associated with Temple syndrome. Clin Epigenetics. 2024;16:62. https:\/\/doi.org\/10.1186\/s13148-024-01652-8. Published 2024 May 7.","journal-title":"Clin Epigenetics"},{"key":"6898_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1210\/endrev\/bnad002","volume":"44","author":"ACS Hokken-Koelega","year":"2023","unstructured":"Hokken-Koelega ACS, van der Steen M, Boguszewski MCS, et al. International consensus guideline on small for gestational age: etiology and management from infancy to early adulthood. Endocr Rev. 2023;44:539\u201365. https:\/\/doi.org\/10.1210\/endrev\/bnad002.","journal-title":"Endocr Rev"},{"key":"6898_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12519-022-00653-y","volume":"19","author":"RQ Cheng","year":"2023","unstructured":"Cheng RQ, Ying YQ, Qiu ZQ, et al. Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome. World J Pediatr. 2023;19:438\u201349. https:\/\/doi.org\/10.1007\/s12519-022-00653-y.","journal-title":"World J Pediatr"},{"key":"6898_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/jcrpe.galenos.2019.2018.0249","volume":"12","author":"D Carli","year":"2020","unstructured":"Carli D, Riberi E, Ferrero GB, Mussa A. Syndromic disorders caused by disturbed human imprinting. J Clin Res Pediatr Endocrinol. 2020;12:1\u201316. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2019.2018.0249.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"6898_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ajmg.a.38533","volume":"176","author":"A Lande","year":"2018","unstructured":"Lande A, Kroken M, Rabben K, Retterst\u00f8l L. Temple syndrome as a differential diagnosis to Prader-Willi syndrome: Identifying three new patients. Am J Med Genet Part A. 2018;176:175\u201380. https:\/\/doi.org\/10.1002\/ajmg.a.38533.","journal-title":"Am J Med Genet Part A"},{"key":"6898_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13148-020-00949-8","volume":"12","author":"K Hara-Isono","year":"2020","unstructured":"Hara-Isono K, Matsubara K, Fuke T, et al. Genome-wide methylation analysis in silver-russell syndrome, temple syndrome, and prader-willi syndrome. Clin Epigenetics. 2020;12:159. https:\/\/doi.org\/10.1186\/s13148-020-00949-8. Published 2020 Oct 22.","journal-title":"Clin Epigenetics"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06898-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06898-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06898-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T02:20:36Z","timestamp":1781749236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06898-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6898"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06898-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Capital Center for Children\u2019s Health, Capital Medical University (SHERLLM2025055). All procedures were performed in accordance with the Declaration of Helsinki. Participating centers provided anonymized clinical data only and were not involved in patient contact or intervention; therefore, additional ethics approval was not required according to institutional policies. The requirement for informed consent to participate was waived by the Ethics Committee due to the retrospective nature of the study and the use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"574"}}